PM vs TPB
PM: A leading international tobacco company rapidly pivoting its global portfolio from combustible cigarettes to science-based smoke-free nicotine alternatives like IQOS and ZYN. TPB: A diversified manufacturer of tobacco and nicotine products navigating the evolving regulatory landscape of the consumer staples sector.
Side-by-side fundamentals
| Metric | PM | TPB | Edge |
|---|---|---|---|
| Price as of 2026-10-21 close | $197.46 | $64.61 | |
| Market cap | $307.8B | $1.3B | |
| P/E as of 2026-10-21 | 28.41 | 28.09 | TPB lower |
| PEG as of 2026-10-21, 3-year EPS CAGR to FY2025 | 3.69 | n/a | |
| Net margin FY2025, SEC XBRL | +27.9% | n/a | |
| Gross margin FY2025, SEC XBRL | +67.1% | n/a | |
| Operating margin FY2025, SEC XBRL | +36.6% | n/a | |
| ROE FY2025, SEC XBRL | n/a | +15.6% | |
| ROA FY2025, SEC XBRL | +16.4% | +7.6% | PM higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | n/a | 0.65 | |
| Revenue growth (YoY) FY2025, SEC XBRL | +7.3% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +8.6% | +12.6% | TPB higher |
| Dividend yield as of 2026-09-02 | +3.2% | +0.5% | PM higher |
| Dividend streak (yrs) SEC XBRL | 18 | 4 | PM higher |
| Beta as of 2026-09-02 | 0.01 | 0.61 | |
| 1-year return as of 2026-10-21 close | +29.9% | -24.3% | PM higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.